HOME >> BIOLOGY >> NEWS
Newly Identified Molecular Mechanism Could Lead To New Approaches For Preventing,,Heart Attack, Stroke

UC San Francisco researchers have identified a molecular mechanism that may play an important role in activating platelets, the blood cells that coagulate to stop bleeding but also cause the clots leading to heart attack and stroke. The finding, published in the August 13 issue of Nature, requires further investigation, said the senior author of the study, Shaun R. Coughlin, MD, PhD, director of the Cardiovascular Research Institute (CRVI) and professor of medicine and cellular and molecular pharmacology at UCSF, but it could provide a new avenue for developing drugs for preventing heart attack and stroke.

The study, conducted in mice and on human platelets, explored the way in which the enzyme known as thrombin, one of several factors known to activate platelets, stimulates the blood cells into action. The initial observations in mice led the researchers to a potentially profound finding for humans.

In the mouse study, the researchers determined that thrombin is able to activate platelets by latching onto, and cleaving, a newly identified receptor in the membrane of the cells. When the enzyme (a protease) binds to the receptor, it instigates the transmembrane signaling that prompts platelet aggregation. The researchers named the receptor protease activated receptor (PAR) 4.

The investigators had previously identified a PAR in human platelets, which they named PAR1. They also had previously identified a PAR in mouse platelets, which they named PAR3.

In the current study, they created a mouse model with platelets lacking PAR3 and found that while the mice had a markedly delayed and diminished response to thrombin activation the response was not totally absent. The discovery of PAR4 explained the continued response. "We determined that PAR3 is necessary for normal thrombin responses in mouse platelets, but that PAR4 does contribute to thrombin signaling," said Coughlin.

The discovery that PAR3 and PAR4 appear to act as a dual-receptor syst
'"/>

Contact: Jennifer O'Brien
jobrien@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
12-Aug-1998


Page: 1 2 3

Related biology news :

1. Newly identified master gene key in babys first breath
2. Newly discovered protein may be key to muscular dystrophy
3. Newly designed nanoparticle quantum dots simultaneously target and image prostate tumors in mice
4. Newly grown kidneys can sustain life in rats
5. Newly discovered gene controls levels of bad cholesterol in mice
6. Newly identified gene linked to brain development
7. Newly cloned gene key to global adaptation of wheat
8. Newly identified genes may help predict outcome in childhood leukemia
9. Newly identified gene may halt fuzzy, moldy fruit
10. Newly found gene resistant to economically crippling wheat disease
11. Newly invented Endometrial Function Test (EFT®) solves the puzzle of unexplained infertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... 2017 , ... DuPont Pioneer and recently formed CasZyme, a ... a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The goal of ... across all applications. , Under the terms of the agreement, Pioneer will provide ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/10/2017)... DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... as part of its corporate rebranding initiative announced today. The bold new look ... its reach, as the company moves into a significant growth period. , It will ...
Breaking Biology Technology:
Cached News: